Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)

AIMS: Insulin glargine 300 U/mL (Gla‐300) offers a flatter pharmacodynamic profile than insulin glargine 100 U/mL (Gla‐100). We have compared these insulins over 1 year in people with type 1 diabetes (T1DM). METHODS: EDITION 4 was a 6‐month, multicentre, randomized, open‐label phase 3 study. People...

Descripción completa

Detalles Bibliográficos
Autores principales: Home, Philip D., Bergenstal, Richard M., Bolli, Geremia B., Ziemen, Monika, Rojeski, Maria, Espinasse, Melanie, Riddle, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763343/
https://www.ncbi.nlm.nih.gov/pubmed/28661585
http://dx.doi.org/10.1111/dom.13048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763343/
https://www.ncbi.nlm.nih.gov/pubmed/28661585
http://dx.doi.org/10.1111/dom.13048

Ejemplares similares